SeQuent Scientific, an integrated pharmaceutical company, witnessed a rise in share price on Friday after it today announced that Alivira Animal Health and Lyka Exports have entered into a definitive agreement under which Alivira will acquire the Animal Health business of Lyka on a "going concern" basis.

Alvira Animal Healthcare is the subsidiary company of SeQuent and Lyka Exports is the subsidiary company of Lyka Labs.

The proposed acquisition of Lyka's Animal Health business includes all IPRs, sales, marketing, distribution network with related employees, contracts, assets and liabilities.

Shares of Sequent Scientific are trading at Rs 835.00, up Rs 10, or 1.21% at the Bombay Stock Exchange (BSE) on Friday at 1:19 p.m.

The scrip has touched an intra-day high of Rs 889.00 and low of Rs 827.50. The total volume of shares traded at the BSE is 21,996.